Answers are grounded in this paper and cite their sources.
The treatment of female-to-male transsexuals with long-acting testosterone undecanoate may be a feasible and safe option for testosterone augmentation in these subjects. However, monitoring of blood pressure should not be ignored during the treatment, to identify patients liable to develop hypertension.
No takes yet. Share an insight, caveat, or question.
Mueller et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: